Pharmaceutical companies in Russia want to fine up to 200% of the revenue for selling drug analogs. The Ministry of Economy proposes to punish manufacturers who produce drugs before the patent on the source expires. Starting September 1, 2027, fines may range from 50% to 200% of the proceeds from such sales, and violators' accounts may be seized. Now the maximum fine is only 40 thousand rubles.

Pharmaceutical companies in Russia want to fine up to 200% of the revenue for selling drug analogs. The Ministry of Economy proposes to punish manufacturers who produce drugs before the patent on the source expires. Starting September 1, 2027, fines may range from 50% to 200% of the proceeds from such sales, and violators' accounts may be seized. Now the maximum fine is only 40 thousand rubles.